Liang H, Gu M, Yang C, et al. Sevoflurane inhibits invasion and migration of lung cancer cells by inactivating the p38 MAPK signaling pathway[J].J Anesth, 2012 DOI:10.1007/s00540-011-1317-yOnline.
[4]
Fecher LA,Amaravadi RK,Flaherty KT. The MAPK pathway in melanoma[J]. Curr Opin Oncol,2008,20(2):183-189.
Gomes LR, Terra LF, Wailemann RA, et al.TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells[J]. BMC Cancer, 2012,12(26):1471-2407.
[7]
Derin D, Eralp Y, Ozluk, et al. Lower level of MAPK expression is associated with anthracycline resistance and decreased survival in patients with hormone receptor negative breast cancer[J]. Cancer Invest,2008, 26(7):671-679.
Esteva FJ, Hortobagyi GN, Sahin AA, et al. Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using immunohistochemistry[J]. Pathol Oncol Res 2001, 7(3):171-177.
[10]
Eralp Y, Derin D, Ozluk Y, et al. MAPK over expression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer[J].Annals of Oncology, 2008, 19(4):669-674.
